AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics' Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01)

AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical CDMO, announced that it has supplied the ...

Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)

First radiotherapeutic agent developed by Radiopharm Ventures, the joint venture between Radiopharm Theranostics and MD ...

Influential Women: Allison Kraus, MS, RT(R)(T)(M)(CT)(ARRT) Senior Radiation Therapist At SSM Health St. Louis Hospital

ST. LOUIS, MO, UNITED STATES, February 24, 2026 / EINPresswire.com / — Driving Precision Cancer Care and Patient-Centered Outcomes ...

AtomVie Global Radiopharma Inc.: AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics' Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01)

AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical CDMO, announced that it has supplied the successful dosing of the first ...